CymitQuimica logo

CAS 54856-23-4

:

Betahistine mesylate

Description:
Betahistine mesylate is a pharmaceutical compound primarily used in the treatment of vestibular disorders, such as Ménière's disease. It acts as a histamine analog, primarily functioning as a selective H1 receptor agonist and an H3 receptor antagonist, which helps to improve blood flow in the inner ear and reduce symptoms like vertigo and tinnitus. The substance is typically administered orally and is known for its relatively good bioavailability. Betahistine mesylate is characterized by its solubility in water and its stability under normal storage conditions. The mesylate salt form enhances its pharmacokinetic properties, allowing for better absorption and efficacy. Common side effects may include gastrointestinal disturbances and headaches, but it is generally well-tolerated. As with any medication, it is essential to use betahistine mesylate under medical supervision to ensure appropriate dosing and to monitor for potential interactions with other medications.
Formula:C8H12N2·2CH4O3S
InChI:InChI=1S/C8H12N2.CH4O3S/c1-9-7-5-8-4-2-3-6-10-8;1-5(2,3)4/h2-4,6,9H,5,7H2,1H3;1H3,(H,2,3,4)
InChI key:InChIKey=FUWLKZQYMWTFBA-UHFFFAOYSA-N
SMILES:C(CNC)C1=CC=CC=N1.S(C)(=O)(=O)O
Synonyms:
  • 2-Pyridineethanamine, N-methyl-, dimethanesulfonate
  • 2-Pyridineethanamine, N-methyl-, methanesulfonate (1:2)
  • Betahistine Mesilate
  • Betahistine Mesylate
  • Betahistine dimesylate
  • Bethahistine methanesulfonate
  • Merislon
  • N-methyl-2-(pyridin-2-yl)ethanamine methanesulfonate (1:2)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.